Digital technologies offer more efficient and patient-friendly distribution of the up-to-date manufacturing details and safety advice mandated by regulators. But many firms in the medtech sector are not maximizing the opportunity to deliver regulated product information digitally.
Whatever the short- and longer-term fallout of COVID-19, organizations will need to come back fighting—with new tools at their disposal and ready to raise their game.
A lot of promises are made by organizations about making systems more intuitive, convenient and user-centric, but in reality most improvements tend to be designed to meet regulatory or internal system needs rather than better serve the people who use them. The user experience needs to be modernized, especially in heavily regulated industries where inaccurate or non-compliant labeling is laden with risk.
Timely compliance will ensure that your products will not be considered misbranded.
As the saying goes, if it looks too good to be true, it probably is.
This online series of workshops will arm you with the information you need to overcome challenges and achieve compliance with EU MDR.
Label and packaging artwork processes play an important role in meeting compliance for EU MDR.
By simplifying labeling compliance, companies can focus on better serving current and new markets.
Upgrading your enterprise labeling system could play a key role in ensuring compliance.
U.S. medtech manufacturers must also prepare for the UDI requirements under EU MDR.